RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Liraglutide pharmacokinetics and dose-exposure response in Asian subjects with Type 2 diabetes from China, India and South Korea.

Liraglutide pharmacokinetics and dose-exposure response in Asian subjects with Type 2 diabetes from China, India and South Korea.

Add to Collection
2015 Apr Others Fist_Author_Year_PM

Full Author : ['Ingwersen, S H', 'Petri, K C', 'Tandon, N', 'Yoon, K-H', 'Chen, L', 'Vora, J', 'Yang, W']
Journal Title : Diabetes research and clinical practice
Chapter : Section3
Journal Year : 2015
Cited by : Not Available

AIMS: To investigate the population pharmacokinetics and exposure-response relationship of liraglutide, a human glucagon-like peptide-1 (GLP-1) analogue, in Asian subjects with Type 2 diabetes mellitus. METHODS: Data were derived from a published 16-week,.....

Keywords : ["type diabetes", "south korea", "liraglutide pharmacokinetic", "doseexposure response", "china india", "asian subject"]